Abstract
Renal cancer is the seventh leading malignant condition among men and the 12th among women. It has been estimated that approximately 58,000 new cases of kidney cancer occurred in 2010 and that, in the same year, approximately 13,000 people died from this disease in the USA [1].
Cite
CITATION STYLE
APA
Bahamon, B., & Signoretti, S. (2012). Tissue biomarkers in renal cell carcinoma: Intermediate endpoints in the selection of targeted agents for RCC. In Renal Cell Carcinoma: Translational Biology, Personalized Medicine, and Novel Therapeutic Targets (Vol. 9781461424000, pp. 69–89). Springer US. https://doi.org/10.1007/978-1-4614-2400-0_4
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free